Log In
News

C-Suite Interview with Axcella Therapeutics (AXLA) President & CEO Bill Hinshaw

11/11/2021
Health
0 min read

Noble Capital Markets Senior Research Analyst Robert LeBoyer interviews Axcella Therapeutics President & CEO Bill Hinshaw.

Research, News, and Advanced Market Data on AXLA


View all C-Suite Interviews

About Axcella Therapeutics

Axcella is a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using endogenous metabolic modulator (EMM) compositions. The company’s product candidates are comprised of EMMs and derivatives that are engineered in distinct combinations and ratios to reset multiple biological pathways, improve cellular energetics, and restore homeostasis. Axcella’s pipeline includes lead therapeutic candidates in Phase 2 development for the reduction in risk of overt hepatic encephalopathy (OHE) recurrence, the treatment of Long COVID, and the treatment of non-alcoholic steatohepatitis (NASH). The company’s unique model allows for the evaluation of its EMM compositions through non-IND clinical studies or IND clinical trials. For more information, please visit www.axcellatx.com.

Share
Related News
‌
Release – Great Lakes Dredge & Dock Corporation Schedules Announcement Of 2024 First Quarter Results
4/30/2024
Transportation

Release – Great Lakes Dredge & Dock Corporation Schedules Announcement Of 2024 First Quarter Results

Great Lakes Dredge & Dock Corporation (NASDAQ: GLDD) today announced that it will release the financial results for its three months ended March 31, 2024 on Tuesday, May 7,...
2 min read
‌
Release – Travelzoo Announces Share Repurchase Program
4/30/2024
Media and Entertainment

Release – Travelzoo Announces Share Repurchase Program

Travelzoo® (NASDAQ: TZOO), the club for travel enthusiasts, today announced that its board of directors has authorized the repurchase of up to 1,000,000 shares of the Company’s outstanding common stock. ...
2 min read
‌
Release – Maia Biotechnology Announces Share Purchase By Director Adelina Louie In Private Placement
4/30/2024
Health

Release – Maia Biotechnology Announces Share Purchase By Director Adelina Louie In Private Placement

MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that independent director Ms. Adelina Louie Ngar Yee made an...
4 min read
‌
Release – Maple Gold Provides Operational Update And Announces Annual Equity Incentive Plan Grants
4/30/2024
Natural Resources

Release – Maple Gold Provides Operational Update And Announces Annual Equity Incentive Plan Grants

Maple Gold Mines Ltd. (TSXV: MGM) (OTCQB: MGMLF) (FSE: M3G) (“Maple Gold” or the “Company”) is pleased to provide an operational update related to the advancement of the Company’s gold...
6 min read

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
Log In
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.
Log In